Mercado cerrado -
Otros sitios de cotización
|
Varia. Cinco días. | Varia. 1 de enero. | ||
2,94 USD | +3,16 % | -9,54 % | +26,72 % |
19/03 | MERSANA THERAPEUTICS, INC. : Actualizado a Neutral por JPMorgan Chase | ZM |
29/02 | MERSANA THERAPEUTICS, INC. : Truist Securities Cambia su recomendación a compra | ZM |
Resumen de negocios
Número de empleados: 123
Ventas por actividad
USD en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Antibody Drug Conjugate
100,0
%
| 27 | 100,0 % | 37 | 100,0 % | +38,65 % |
Ventas por región
USD en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 27 | 100,0 % | 37 | 100,0 % | +38,65 % |
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Martin Huber
CEO | Chief Executive Officer | 64 | 13/04/20 |
Director of Finance/CFO | 46 | 10/07/19 | |
David Mott
CHM | Chairman | 58 | 31/07/12 |
Timothy Lowinger
CTO | Chief Tech/Sci/R&D Officer | 60 | 01/02/08 |
Anna Protopapas
BRD | Director/Board Member | 59 | 02/03/15 |
Mohan Bala
PRN | Corporate Officer/Principal | - | 25/10/21 |
Chuck Miller
LAW | General Counsel | - | 31/08/20 |
Ashish Mandelia
AUD | Comptroller/Controller/Auditor | 50 | 01/07/19 |
Tushar Misra
PRN | Corporate Officer/Principal | 64 | 16/08/21 |
General Counsel | 50 | 26/04/21 |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Kristen Hege
BRD | Director/Board Member | 60 | 01/08/16 |
David Mott
CHM | Chairman | 58 | 31/07/12 |
Anna Protopapas
BRD | Director/Board Member | 59 | 02/03/15 |
Andrew Hack
BRD | Director/Board Member | 50 | 06/01/17 |
Martin Huber
CEO | Chief Executive Officer | 64 | 13/04/20 |
Lawrence Alleva
BRD | Director/Board Member | 74 | 05/09/17 |
Allene Diaz
BRD | Director/Board Member | 59 | 09/03/21 |
Willard Dere
BRD | Director/Board Member | 70 | 19/03/18 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 121 303 007 | 119 267 730 ( 98,32 %) | 0 | 98,32 % |
Información de la empresa
Sector
Revisiones del BPA
Varia. 1 de ene. | Capi. | |
---|---|---|
+26,72 % | 360 M | |
-2,31 % | 103 mil M | |
+0,56 % | 95,28 mil M | |
+1,69 % | 22,15 mil M | |
-17,37 % | 21,02 mil M | |
-9,30 % | 18,15 mil M | |
-41,01 % | 16,74 mil M | |
-14,85 % | 16,05 mil M | |
+3,21 % | 13,68 mil M | |
+33,54 % | 12,17 mil M |
- Bolsa de valores
- Acciones
- Acción MRSN
- Empresa Mersana Therapeutics, Inc.